Environment (Protection) Act, 1986 Rules for the manufacture / use / Import / Export and storage of hazardous Micro organisms, GEO or cells (1989) under the EPA Biological diversity act, 2002 Plant quarantine order, 2003 GM policy in foreign trade policy (2006 – 09) Food safety and standards act, 2006 Drugs and cosmetics rule (8 th Amendment), 1988 Applicable acts and rules
Key features of rules 1989
WHAT IS CARTAGENA PROTOCOL? The Cartagena Protocol on Biosafety to the Convention on Biological Diversity is an international agreement which aims to ensure the safe handling, transport and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account risks to human health. It was adopted on 29 January 2000 and entered into force on 11 September 2003.
WHAT IS CARTAGENA PROTOCOL? The Cartagena Protocol is an international agreement managing the movement of living modified organisms from one country to another. It aims to protect nature from the potential risks posed by such organisms by establishing procedures countries can use to make informed decisions on the import of such organisms
IS INDIA A PART OF CARTAGENA PROTOCOL? India is a signatory to the Cartagena Protocol on Biosafety and ratified it on January 23, 2003. As per Article 20 of the Cartagena Protocol on Biosafety, requires set up of Biosafety Clearing House(BCH) in order to facilitate the exchange of scientific, technical environmental and legal information on living modified organisms (LMOs).
CARTAGENA PROTOCOL AIMS AT The Protocol promotes biosafety by establishing rules and procedures for the safe transfer, handling and use of LMOs and facilitates information sharing, including: Procedures for moving LMOs across borders. Risk assessment procedures. The biosafety clearing house. Capacity building. Public awareness.
Elements of the Strategic Plan for the Cartagena Protocol on Biosafety Vision Biological diversity is adequately protected from any adverse effects of living modified organisms Mission To strengthen global, regional & national action and capacity in ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health and specifically focusing on transboundary movements
STRATEGIC OBJECTIVES Focal area 1 : Facilitating the establishment and further development of effective biosafety systems for the implementation of the Protocol Focal area 2 : Capacity building Focal area 3 : Compliance and review Focal area 4 : Information sharing Focal area 5 : Outreach and cooperation
Operational Objectives Focal area 1 : National Biosafety Frameworks Coordination and support Risk assessment and risk management LMOs or traits that may have adverse effects Liability and Redress Handling, transport, packaging and identification Socio-economic considerations Transit, contained use, unintentional transboundary movements and emergency measures
Operational Objectives Focal area 2 : National Biosafety Frameworks Risk assessment and risk management Handling, transport, packaging and identification Liability and Redress Public awareness, education and participation Information sharing Biosafety education and training
Operational Objectives Focal area 3 : Compliance with the Protocol Assessment and review
Operational Objectives Focal area 4 : Biosafety Clearing-House (BCH) effectiveness Biosafety Clearing-House (BCH) as a tool for online discussions and conferences Information sharing other than through the Biosafety Clearing-House (BCH)
Operational Objectives Focal area 5 : Ratification of the Protocol Cooperation Communication and outreach
The Conference of the Parties serving as the meeting of the Parties to the Protocol (COP-MOP) Advance Informed Agreement" (AIA) food or feed, or for processing(FFP)